Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

August 04, 2015 2:13 AM ET


Company Overview of New Haven Pharmaceuticals, Inc.

Executive Profile

Harry H. Penner Jr., J.D.

Co-Founder and Executive Chairman, New Haven Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 5 Board Members in 5 different organizations across 10 different industries.

See Board Relationships


Mr. Harry H. Penner Jr., J.D. serves as an Executive Chairman of New Haven Pharmaceuticals, Inc. Mr. Penner has 28 years of increasing management responsibilities in the pharmaceutical and biotechnology sectors. Mr. Penner co-founded New Haven Pharmaceuticals, Inc. in 2008. He co-founded RHEI Pharmaceuticals, Inc., Deviant Technologies, Inc. and MAKScientific, LLC. He is a co-founder of Affinimark Technologies, Inc. He co-founded Marinus Pharmaceuticals, Inc. in June ...

Corporate Headquarters

142 Temple Street
New Haven, Connecticut 06510

United States

Phone: --
Fax: --

Board Members Memberships

Co-Founder and Executive Chairman
Director, Member of Audit Committee and Member of Compensation Committee


BA 1967
University of Virginia
Master's Degree 1975
New York University
JD 1970
Fordham University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact New Haven Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at